4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-25-038726
Chief Scientific Officer sold 2,153 shares at $11.38 ($24,501)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Beskrovnaya Oxana Chief Scientific Officer | 2025-03-11 | Sale 10b5-1 | −2,153 | $11.38 | $24,501 | 195,840 | D |
| Open-market sales · 2,153 sh · avg $11.38 · $24,501 | |||||||
Loading xslF345X05/ownership.xml…